Abstract
AbstractNinety‐four percent of human genes are discontinuous, such that segments expressed as mRNA are contained within exons and separated by intervening segments, called introns. Following transcription, genes are expressed as precursor mRNAs (pre‐mRNAs), which are spliced co‐transcriptionally, and the flanking exons are joined together to form a continuous mRNA. One advantage of this architecture is that it allows alternative splicing by differential use of exons to generate multiple mRNAs from individual genes. Regulatory elements located within introns and exons guide the splicing complex, the spliceosome, and auxiliary RNA binding proteins to the correct sites for intron removal and exon joining. Misregulation of splicing and alternative splicing can result from mutations in cis‐regulatory elements within the affected gene or from mutations that affect the activities of trans‐acting factors that are components of the splicing machinery. Mutations that affect splicing can cause disease directly or contribute to the susceptibility or severity of disease. An understanding of the role of splicing in disease expands potential opportunities for therapeutic intervention by either directly addressing the cause or by providing novel approaches to circumvent disease processes. Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
References
112
Referenced
326
10.1016/j.cell.2009.02.011
10.1016/j.febslet.2005.02.047
10.1038/ng.259
10.1038/nature07509
10.1016/j.cell.2009.02.009
10.1261/rna.876308
10.1016/j.ceb.2008.03.001
10.1128/MCB.4.6.1104
10.1016/S0968-0004(00)01604-2
10.1002/humu.20400
10.1093/hmg/ddl068
10.1261/rna.868008
10.1038/ng1610
10.1073/pnas.0809045105
10.1101/gad.1788009
10.1007/BF00210743
10.1101/gad.1048803
10.1016/j.bbadis.2008.09.017
10.1038/nrg2164
10.1007/s12017-007-8019-5
10.1074/jbc.M110445200
10.1016/S1097-2765(00)80179-3
10.1016/j.molcel.2006.04.017
10.1086/318808
10.1086/318810
10.1086/368263
10.1002/humu.20401
10.1261/rna.5196404
10.1093/hmg/9.2.259
10.1073/pnas.96.11.6307
10.1093/hmg/8.7.1177
10.1038/ng1207
10.1093/hmg/ddm276
10.1086/498853
10.1038/ng854
10.1086/511992
10.1016/j.spen.2008.05.008
10.1186/1471-2164-9-265
10.1136/jmg.2007.052746
10.1038/ng0193-7
10.1038/ng0193-14
10.1038/ng0193-20
10.1056/NEJM198007103030201
{'key': 'e_1_2_16_45_2', 'first-page': '71', 'article-title': 'Skeletal dysplasia, occipital horns, diarrhea and obstructive uropathy—a new hereditary syndrome', 'volume': '11', 'author': 'Lazoff SG', 'year': '1975', 'journal-title': 'Birth Defects Orig Artic Ser'}
/ Birth Defects Orig Artic Ser / Skeletal dysplasia, occipital horns, diarrhea and obstructive uropathy—a new hereditary syndrome by Lazoff SG (1975)10.1007/s00439-003-1045-y
10.1007/978-1-4615-4859-1_7
{'key': 'e_1_2_16_48_2', 'first-page': '570', 'article-title': 'Similar splicing mutations of the Menkes/mottled copper‐transporting ATPase gene in occipital horn syndrome and the blotchy mouse', 'volume': '56', 'author': 'Das S', 'year': '1995', 'journal-title': 'Am J Hum Genet'}
/ Am J Hum Genet / Similar splicing mutations of the Menkes/mottled copper‐transporting ATPase gene in occipital horn syndrome and the blotchy mouse by Das S (1995)10.1038/ng1094-195
10.1086/302857
10.1073/pnas.96.10.5598
10.1126/science.282.5395.1914
10.1186/1750-1326-3-8
10.1007/s00018-004-4001-7
10.1038/nrc1412
10.1016/0092-8674(93)90508-N
{'key': 'e_1_2_16_57_2', 'first-page': '1567', 'article-title': 'Immunohistochemical analysis of bcl‐2, bax, bcl‐X, and mcl‐1 expression in prostate cancers', 'volume': '148', 'author': 'Krajewska M', 'year': '1996', 'journal-title': 'Am J Pathol'}
/ Am J Pathol / Immunohistochemical analysis of bcl‐2, bax, bcl‐X, and mcl‐1 expression in prostate cancers by Krajewska M (1996){'key': 'e_1_2_16_58_2', 'first-page': '230', 'article-title': 'Overexpression of BCL‐x protein in primary breast cancer is associated with high tumor grade and nodal metastases', 'volume': '3', 'author': 'Olopade OI', 'year': '1997', 'journal-title': 'Cancer J Sci Am'}
/ Cancer J Sci Am / Overexpression of BCL‐x protein in primary breast cancer is associated with high tumor grade and nodal metastases by Olopade OI (1997)10.1038/bjc.1996.230
{'key': 'e_1_2_16_60_2', 'first-page': '256', 'article-title': 'BCL‐X expression in multiple myeloma: possible indicator of chemoresistance', 'volume': '58', 'author': 'Tu Y', 'year': '1998', 'journal-title': 'Cancer Res'}
/ Cancer Res / BCL‐X expression in multiple myeloma: possible indicator of chemoresistance by Tu Y (1998){'key': 'e_1_2_16_61_2', 'first-page': '2507', 'article-title': 'Overexpression of Bcl‐XS sensitizes MCF‐7 cells to chemotherapy‐induced apoptosis', 'volume': '55', 'author': 'Sumantran VN', 'year': '1995', 'journal-title': 'Cancer Res'}
/ Cancer Res / Overexpression of Bcl‐XS sensitizes MCF‐7 cells to chemotherapy‐induced apoptosis by Sumantran VN (1995)10.1016/j.cell.2008.03.031
10.1093/emboj/20.7.1774
10.1016/j.bbrc.2006.10.093
10.1126/science.1134108
10.1126/science.1166066
10.1126/science.1165942
10.1016/j.cell.2009.03.006
10.1038/nrg1691
{'key': 'e_1_2_16_70_2', 'volume-title': 'Myotonic Dystrophy', 'author': 'Harper PS', 'year': '2001'}
/ Myotonic Dystrophy by Harper PS (2001)10.1126/science.1546325
10.1002/humu.1380010302
10.1126/science.1062125
10.1073/pnas.94.14.7388
10.1093/hmg/ddl132
10.1126/science.1088583
10.1074/jbc.M410781200
10.1038/ng704
10.1016/j.molcel.2007.07.027
10.1016/S1097-2765(02)00572-5
10.1016/S1097-2765(02)00563-4
{'key': 'e_1_2_16_82_2', 'first-page': '3952', 'article-title': 'Correction of ClC‐1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy', 'volume': '117', 'author': 'Wheeler TM', 'year': '2007', 'journal-title': 'J Clin Invest'}
/ J Clin Invest / Correction of ClC‐1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy by Wheeler TM (2007)10.1038/embor.2008.189
10.1038/nature07638
10.1242/jcs.03053
10.1002/bies.20390
10.1158/0008-5472.CAN-03-2818
10.1158/0008-5472.CAN-04-0185
10.1126/science.1066326
10.1038/sj.onc.1208020
10.1016/j.drup.2008.11.001
10.1158/0008-5472.CAN-05-0217
10.1158/0008-5472.CAN-04-4249
10.1172/JCI34780
10.1016/j.clindermatol.2008.09.005
10.1002/gcc.1159
10.1038/sj.onc.1208587
10.1016/S1525-1578(10)60533-8
{'key': 'e_1_2_16_99_2', 'first-page': '1085', 'article-title': 'Expression of splicing factors in human ovarian cancer', 'volume': '11', 'author': 'Fischer DC', 'year': '2004', 'journal-title': 'Oncol Rep'}
/ Oncol Rep / Expression of splicing factors in human ovarian cancer by Fischer DC (2004)10.1038/nsmb1209
10.1073/pnas.96.17.9689
10.1016/j.molcel.2005.10.026
10.1042/BST0360483
10.1074/jbc.R700034200
10.1074/jbc.M311512200
10.1016/S0301-0082(01)00011-9
10.1046/j.1432-1033.2003.03555.x
10.1016/0022-510X(90)90195-S
{'key': 'e_1_2_16_109_2', 'first-page': '1007', 'article-title': 'Exon skipping and translation in patients with frameshift deletions in the dystrophin gene', 'volume': '53', 'author': 'Sherratt TG', 'year': '1993', 'journal-title': 'Am J Hum Genet'}
/ Am J Hum Genet / Exon skipping and translation in patients with frameshift deletions in the dystrophin gene by Sherratt TG (1993)10.1261/rna.653607
10.1016/j.cell.2009.02.010
10.1073/pnas.0905780106
10.1126/science.1173110
Dates
Type | When |
---|---|
Created | 15 years, 9 months ago (Nov. 13, 2009, 8:36 a.m.) |
Deposited | 1 year, 11 months ago (Sept. 13, 2023, 5:43 a.m.) |
Indexed | 1 week, 5 days ago (Aug. 20, 2025, 8:53 a.m.) |
Issued | 15 years, 9 months ago (Nov. 13, 2009) |
Published | 15 years, 9 months ago (Nov. 13, 2009) |
Published Online | 15 years, 9 months ago (Nov. 13, 2009) |
Published Print | 15 years, 8 months ago (Jan. 1, 2010) |
@article{Ward_2009, title={The pathobiology of splicing}, volume={220}, ISSN={1096-9896}, url={http://dx.doi.org/10.1002/path.2649}, DOI={10.1002/path.2649}, number={2}, journal={The Journal of Pathology}, publisher={Wiley}, author={Ward, Amanda J and Cooper, Thomas A}, year={2009}, month=nov, pages={152–163} }